Federated Hermes, Inc. Vertex Pharmaceuticals Inc Transaction History

Federated Hermes, Inc.

$41.2 Billion
Q2 2024

A detailed history of Federated Hermes, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Federated Hermes, Inc. holds 211,642 shares of VRTX stock, worth $109 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

211,642

Previous 211,915 0.13%

Holding current value

$109 Million

Previous $88.6 Million 11.99%

% of portfolio

0.24%

Previous 0.21%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$392.81 - $485.53 $107,237 - $132,549	-273 Reduced 0.13%	211,642 $99.2 Million
Q1 2024 May 14, 2024	BUY	$407.69 - $446.08 $2.67 Million - $2.92 Million	6,554 Added 3.19%	211,915 $88.6 Million
Q4 2023 Jan 31, 2024	BUY	$343.0 - $410.68 $4.3 Million - $5.15 Million	12,542 Added 6.5%	205,361 $83.6 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $12 Million - $12.8 Million	35,371 Added 22.47%	192,819 $67.1 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $3.84 Million - $4.3 Million	-12,211 Reduced 7.2%	157,448 $55.4 Million
Q1 2023 May 08, 2023	BUY	$283.23 - $323.1 $5.28 Million - $6.02 Million	18,637 Added 12.34%	169,659 $53.5 Million
Q4 2022 Feb 13, 2023	SELL	$285.76 - $321.48 $1.53 Million - $1.73 Million	-5,368 Reduced 3.43%	151,022 $43.6 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $5.48 Million - $6.11 Million	-20,001 Reduced 11.34%	156,390 $45.3 Million
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $15 Million - $18.7 Million	-63,757 Reduced 26.55%	176,391 $49.7 Million
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $5.96 Million - $7.03 Million	-26,936 Reduced 10.09%	240,148 $62.7 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $2.91 Million - $3.67 Million	16,440 Added 6.56%	267,084 $58.7 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $14.3 Million - $16 Million	78,580 Added 45.67%	250,644 $45.5 Million
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $18.5 Million - $21.8 Million	-98,665 Reduced 36.44%	172,064 $34.7 Million
Q1 2021 May 13, 2021	SELL	$207.02 - $241.31 $12.3 Million - $14.4 Million	-59,586 Reduced 18.04%	270,729 $58.2 Million
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $6.41 Million - $8.54 Million	-30,941 Reduced 8.56%	330,315 $78.1 Million
Q3 2020 Nov 12, 2020	SELL	$255.65 - $303.1 $838,276 - $993,864	-3,279 Reduced 0.9%	361,256 $98.3 Million
Q2 2020 Aug 13, 2020	SELL	$225.48 - $295.8 $7.74 Million - $10.2 Million	-34,322 Reduced 8.61%	364,535 $106 Million
Q1 2020 May 13, 2020	SELL	$199.77 - $247.81 $1.97 Million - $2.45 Million	-9,873 Reduced 2.42%	398,857 $94.9 Million
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $4.58 Million - $6.15 Million	27,454 Added 7.2%	408,730 $89.5 Million
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $9.4 Million - $10.6 Million	56,546 Added 17.41%	381,276 $64.6 Million
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $605,764 - $700,561	-3,680 Reduced 1.12%	324,730 $59.5 Million
Q1 2019 May 10, 2019	BUY	$163.73 - $194.7 $12.2 Million - $14.5 Million	74,720 Added 29.45%	328,410 $60.4 Million
Q4 2018 Feb 13, 2019	SELL	$151.91 - $192.21 $7.28 Million - $9.22 Million	-47,947 Reduced 15.9%	253,690 $42 Million
Q3 2018 Nov 13, 2018	SELL	$167.73 - $192.74 $15.8 Million - $18.2 Million	-94,217 Reduced 23.8%	301,637 $58.1 Million
Q2 2018 Aug 10, 2018	BUY	$145.72 - $169.96 $22.5 Million - $26.2 Million	154,169 Added 63.79%	395,854 $67.3 Million
Q1 2018 May 09, 2018	BUY	$151.6 - $177.13 $29.2 Million - $34.1 Million	192,425 Added 390.63%	241,685 $39.4 Million
Q4 2017 Feb 14, 2018	SELL	$137.28 - $155.55 $278,129 - $315,144	-2,026 Reduced 3.95%	49,260 $0
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $7.6 Million - $8.32 Million	51,286	51,286 $7.8 Million

Others Institutions Holding VRTX

# of Institutions

1,717

Shares Held

226M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $133B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Vertex Pharmaceuticals Inc Transaction History